國立虎尾科技大學 |

Relationship between Quality of Life for Patients with Neuroendocrine Tumors and Novel Biomarkers.

紀錄類型:	書目-語言資料,手稿 : Monograph/item
正題名/作者:	Relationship between Quality of Life for Patients with Neuroendocrine Tumors and Novel Biomarkers./
作者:	Ford-Scheimer, Stephanie L.
面頁冊數:	1 online resource (123 pages)
附註:	Source: Dissertation Abstracts International, Volume: 78-06(E), Section: B.
Contained By:	Dissertation Abstracts International78-06B(E).
標題:	Epidemiology. -
電子資源:	click for full text (PQDT)
ISBN:	9781369552393

Relationship between Quality of Life for Patients with Neuroendocrine Tumors and Novel Biomarkers.
Ford-Scheimer, Stephanie L.

Relationship between Quality of Life for Patients with Neuroendocrine Tumors and Novel Biomarkers. - 1 online resource (123 pages)

Source: Dissertation Abstracts International, Volume: 78-06(E), Section: B.

Thesis (Ph.D.)

Includes bibliographical references

Research in the field of neuroendocrine tumors (NETs) has increased over the last decade, including studies focused on biochemical markers (biomarkers) of the disease. There is also growing interest in how NETs impact patients' quality of life (QOL). Consequently, there is a paucity of information about whether the expression of the specific disease biomarkers affects QOL as well as whether the primary tumor site impacts QOL. Using the explanatory model of health promotion and quality of life in chronic disabling conditions as the theoretical framework and data collected with the Norfolk QOL-NET instrument, this study's purpose was to fill that gap in knowledge through research questions addressing the relationship between the primary tumor site and NET patients' total QOL score as well as the effect of specific NET biomarkers on NET patients' total QOL score. Data were analyzed using descriptive statistics, one-way analysis of variance (ANOVA), regression analysis, and post hoc tests to determine significance. Results from an ANOVA showed that abnormal NET biomarkers affected total QOL (p = 0.011). In the analyses of whether the independent biomarker variables affected the dependent total QOL variable, only the result for Serotonin Normal was significant (p = 0.002). The presence of abnormal biomarker measurements also affected two of the Norfolk QOL-NET domains significantly, gastrointestinal and physical functioning (p = 0.005 and p = 0.030, respectively). By understanding the relationship between NETs and patient QOL, the potential positive social change implications are helping NET patients assess the severity of their condition, determining what affects their well-being, and using this information to help monitor their treatment/progress.

Electronic reproduction.
Ann Arbor, Mich. :
ProQuest,
2018

Mode of access: World Wide Web

ISBN: 9781369552393Subjects--Topical Terms:

635923
Epidemiology.
Index Terms--Genre/Form:

554714
Electronic books.

Relationship between Quality of Life for Patients with Neuroendocrine Tumors and Novel Biomarkers.
LDR:03052ntm a2200337Ki 4500 001 910891
005 20180517120323.5
006 m o u
007 cr mn||||a|a||
008 190606s2017 xx obm 000 0 eng d
020 $a 9781369552393
035 $a (MiAaPQ)AAI10256285
035 $a (MiAaPQ)waldenu:18521
035 $a AAI10256285
040 $a MiAaPQ $b eng $c MiAaPQ
099 $a TUL $f hyy $c available through World Wide Web
100 1 $a Ford-Scheimer, Stephanie L. $3 1182394
245 1 0 $a Relationship between Quality of Life for Patients with Neuroendocrine Tumors and Novel Biomarkers.
264 0 $c 2017
300 $a 1 online resource (123 pages)
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
500 $a Source: Dissertation Abstracts International, Volume: 78-06(E), Section: B.
500 $a Adviser: Diana Naser.
502 $a Thesis (Ph.D.) $c Walden University $d 2017.
504 $a Includes bibliographical references
520 $a Research in the field of neuroendocrine tumors (NETs) has increased over the last decade, including studies focused on biochemical markers (biomarkers) of the disease. There is also growing interest in how NETs impact patients' quality of life (QOL). Consequently, there is a paucity of information about whether the expression of the specific disease biomarkers affects QOL as well as whether the primary tumor site impacts QOL. Using the explanatory model of health promotion and quality of life in chronic disabling conditions as the theoretical framework and data collected with the Norfolk QOL-NET instrument, this study's purpose was to fill that gap in knowledge through research questions addressing the relationship between the primary tumor site and NET patients' total QOL score as well as the effect of specific NET biomarkers on NET patients' total QOL score. Data were analyzed using descriptive statistics, one-way analysis of variance (ANOVA), regression analysis, and post hoc tests to determine significance. Results from an ANOVA showed that abnormal NET biomarkers affected total QOL (p = 0.011). In the analyses of whether the independent biomarker variables affected the dependent total QOL variable, only the result for Serotonin Normal was significant (p = 0.002). The presence of abnormal biomarker measurements also affected two of the Norfolk QOL-NET domains significantly, gastrointestinal and physical functioning (p = 0.005 and p = 0.030, respectively). By understanding the relationship between NETs and patient QOL, the potential positive social change implications are helping NET patients assess the severity of their condition, determining what affects their well-being, and using this information to help monitor their treatment/progress.
533 $a Electronic reproduction. $b Ann Arbor, Mich. : $c ProQuest, $d 2018
538 $a Mode of access: World Wide Web
650 4 $a Epidemiology. $3 635923
655 7 $a Electronic books. $2 local $3 554714
690 $a 0766
710 2 $a ProQuest Information and Learning Co. $3 1178819
710 2 $a Walden University. $b Public Health. $3 1182395
773 0 $t Dissertation Abstracts International $g 78-06B(E).
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=10256285 $z click for full text (PQDT)